Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- WITHDRAWN
- Phase
- PHASE2
Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab
- Status
- COMPLETED
- Phase
- N/A
Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab
- Status
- WITHDRAWN
- Phase
- PHASE3
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- NA
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer
- Status
- TERMINATED
- Phase
- NA
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response
- Status
- COMPLETED
- Phase
- PHASE2
AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2801653 in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1